IPN Ipsen SA

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025

Aggregated presentation by day and by market

Statement of transactions in own shares from June 2nd to June 6th 2025
       
Name of the issuerIdentity code of the issuer

(Legal Entity Identifier)
Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket         (MIC Code)
IPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150   294   102,63197AQEU
IPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150   929   102,90904CCXE
IPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150   288   102,59167TQEX
IPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150  3 069   103,02822XPAR
IPSEN549300M6SGDPB4Z94P1103/06/2025FR0010259150   294   103,98571AQEU
IPSEN549300M6SGDPB4Z94P1103/06/2025FR0010259150   929   104,26491CCXE
IPSEN549300M6SGDPB4Z94P1103/06/2025FR0010259150   288   104,0691TQEX
IPSEN549300M6SGDPB4Z94P1103/06/2025FR0010259150  2 427   103,81108XPAR
IPSEN549300M6SGDPB4Z94P1104/06/2025FR0010259150   504   103,79246AQEU
IPSEN549300M6SGDPB4Z94P1104/06/2025FR0010259150  1 186   103,48668CCXE
IPSEN549300M6SGDPB4Z94P1104/06/2025FR0010259150   354   103,62825TQEX
IPSEN549300M6SGDPB4Z94P1104/06/2025FR0010259150  3 306   103,68297XPAR
IPSEN549300M6SGDPB4Z94P1105/06/2025FR0010259150   300   104,26667AQEU
IPSEN549300M6SGDPB4Z94P1105/06/2025FR0010259150   750   104,04667CCXE
IPSEN549300M6SGDPB4Z94P1105/06/2025FR0010259150   250   103,94TQEX
IPSEN549300M6SGDPB4Z94P1105/06/2025FR0010259150  2 794   104,08021XPAR
IPSEN549300M6SGDPB4Z94P1106/06/2025FR0010259150   200   103,82AQEU
IPSEN549300M6SGDPB4Z94P1106/06/2025FR0010259150   400   103,825CCXE
IPSEN549300M6SGDPB4Z94P1106/06/2025FR0010259150   200   103,875TQEX
IPSEN549300M6SGDPB4Z94P1106/06/2025FR0010259150  4 250   103,90626XPAR
   TOTAL23 012 103,6915 



 

Attachment



EN
13/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

 PRESS RELEASE

IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025  Aggregated presentation by day and by market  Statement of transactions in own shares from June 23rd to June 27th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market         (MIC Code) IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150    335    100,58955 AQEU   IPSEN 549300M6SGDPB4Z94P11 ...

 PRESS RELEASE

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règleme...

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2025 Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 23 juin au 27 juin 2025  Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'acquisition Code identifiant marché IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150    335    100,58955 AQEU IPSEN 549300M6SGDPB4Z94P11 23/06/20...

 PRESS RELEASE

IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025  Aggregated presentation by day and by market               Statement of transactions in own shares from June 16th to June 20th 2025 Name of the issuerIdentity code of the issuer (Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)  IPSEN549300M6SGDPB4Z94P1116/06/2025FR0010259150   140   103,60AQEUIPSEN549300M6SGDPB4Z94P1116/06/2025FR0010259150   221   103,50CCXEIPSEN549300M6SGDPB4Z94P111...

 PRESS RELEASE

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règleme...

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2025  Présentation agrégée par jour et par marché           Déclaration des transactions sur actions propres réalisées du 16 juin au 20 juin 2025         Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'acquisition Code identifiant marché IPSEN 549300M6SGDPB4Z94P11 16/06/2025 FR0010259150    140    103,60 AQEU   IPSEN 549300M6SGDPB...

 PRESS RELEASE

Ipsen receives positive CHMP opinion for Cabometyx® in previously trea...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy1,2Recommendation based on CABINET Phase III trial results, which demonstrated statistically significant and clinically meaningful reductions in risk of disease progression or death with Cabometyx versus placebo3,4European Commission decision expected Q3...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch